In this Wellness Unmasked Weekly Rundown, Dr. Nicole Saphier breaks down two urgent developments in the world of health and wellness. First, she unpacks the FDA's move to schedule 7-hydroxymitragynine (7-OH)—a synthetic Kratom derivative up to 13 times stronger than morphine—as a Schedule I controlled substance. What does this mean for wellness supplements, and how did these potent, unregulated substances make it to market in the first place?
Then, Dr. Saphier dives into the White House’s new AI-driven healthcare initiative. While tech giants like Amazon, Google, and Apple promise to revolutionize healthcare with data transparency and streamlined systems, concerns mount over data privacy, conflicts of interest, and regulatory oversight. Are Silicon Valley insiders set to profit from policies they help shape? Wellness Unmasked is part of the Clay Travis & Buck Sexton Podcast Network - new episodes debut every Tuesday & Friday.

Wellness Unmasked Weekly Rundown: Why Allergy Season Keeps Getting Worse (And What You Can Do About It)
06:13

Wellness Unmasked: The Hidden Danger of “Gas Station Heroin”: What Parents Need to Know About Tianeptine
12:35

Wellness Unmasked Weekly Rundown: Pentagon Ends Flu Vaccine Mandate—Medical Freedom or Military Risk?
08:05